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We report the application of matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS) for the accurate measurement of mass of low molecular
weight compounds (smaller than 1500 Da), a linear peptide, two types of cyclic depsipeptides,
a polyhydroxy-macrocyclic lactone, and two prenylated flavonoids, with delayed extraction in
the reflector mode. The performance of the MALDI-TOF instrument was less than those of fast
atom bombardment and Fourier-transform ion cyclotron resonance mass spectrometry instru-
ments and insufficient to give acceptable accuracy for literature reporting. Nevertheless, when
combined with NMR spectrometry and/or amino acid analysis to give information on the
numbers of carbon atoms and index of hydrogen deficiency, MALDI was useful for
determination of the elemental composition of the low molecular weight compounds available
in small quantities. (J Am Soc Mass Spectrom 2000, 11, 458–463) © 2000 American Society
for Mass Spectrometry
Elemental analysis is essential for the structuralproof of synthetic and natural products. Accuratemass measurements are also used as proof when
elemental analysis is not utilized because the quantity
of available sample is low, such as for low yield natural
products. When electron ionization (EI) mass spectro-
metry can be used, 1–10 pmol samples are required for
one measurement. This loss of sample is usually accept-
able even when subsequent biological testing is needed.
However, when fast atom bombardment (FAB) mass
spectrometry is used, 0.1–1 nmol is required for one
measurement, and the elemental composition is deter-
mined in the final stage. A further disadvantage of the
FAB method is that it is labor intensive, requiring an
expert mass spectrometry instrument operator, and is
time consuming [1]. Although the development of mod-
ern two-dimensional nuclear magnetic resonance
(NMR) spectroscopy, especially the pulsed field gradi-
ent technique, and improved sensitivity now permit
structural determination with small quantities of sam-
ple, we use high-resolution FAB mass spectrometry for
final confirmation of the formula. Generally, the accept-
able accuracy of exact masses for identification pur-
poses is within 5 ppm (EI and chemical ionization) or 10
ppm (FAB or liquid secondary ionization mass spectro-
metry), e.g., “Instructions for Authors (1999),” J. Chem.
Soc., Perkin Trans. 1., web site of Royal Society of
Chemistry. A few journals suggested the addition of a
standard deviation of the measurement data, e.g., “Ed-
itorial,” J. Am. Soc. Mass Spectrom. [2], “1999 Guidelines
for Authors,” J. Org. Chem. 1999, 64, 16A–21A. Accurate
mass measurements by FAB MS are useful for determi-
nation of structure, but sometimes it is necessary to
forego examination of some biological activities of the
compound because the sample loss for FAB is too large.
Matrix-assisted laser desorption/ionization time-of-
flight (MALDI-TOF) mass spectrometry requires
smaller amounts of sample, and no special skill is
required to operate the instrument. Subpicomole
amounts of sample are adequate for multiple analyses,
and this type of spectrometry is applicable for low as
well as high molecular weight compounds [3].
Accurate mass measurements of protonated mole-
cules of low molecular weight compounds with
MALDI-TOF MS have been obtained although no de-
tails were given (Nihon PerSeptive, personal communi-
cation, the data obtained with Voyager Elite in their US
laboratory) [4]. As methods for accurate mass determi-
nation of small sample sizes are required, we evaluated
accurate mass measurement with MALDI-TOF MS. We
report here accurate mass measurement of low molec-
ular weight natural products (, 1500 Da) with delayed
extraction MALDI-TOF MS in the reflector mode.
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Experimental
All MALDI mass spectra were obtained on a Voyag-
er-DE STR (PerSeptive Biosystems, Framingham, MA)
TOF mass spectrometer equipped with a nitrogen laser
(337 nm), TDS 540C 500 MHz digitizing oscilloscope
(500 MHz bandwidth, 2G samples/s, Tektronix inc.,
Beaverton, OR), PerSeptive Biospectrometry Worksta-
tion (Version 3.09) and PerSeptive GRAMS/386 for
Microsoft Windows (Version 3.04 Level III, Driver Ver-
sion 1.00, Galactic Industries, Salem, NH). The instru-
ment was operated in the delayed extraction reflector
mode, and the delay time was 180–200 ns. The number
of data points was 50 000, and the time interval between
data points was 0.5 ns. The acceleration voltage was 20
kV and the grid voltage was 14.7 kV. The protonated
molecules of the analyte and the internal standards
were situated in a suitable range of the spectrum by
cutting out the lower mass range using a low-mass gate.
Each mass spectrum was an average of 128 laser shots.
The resolving power for angiotensin II at m/z 1046 was
7900–13 000 (full width at half height) when the col-
lected mass range was 800–2050 Da and the peak
shapes were described with 9–12 data points. Calibra-
tion was performed as two-point calibration with the
Voyager software, and centroiding percentage in the
calibration was top 30% of the reference peaks. Un-
knowns were also calculated with the top 30% of the
peaks.
Approximately 0.4 mL of 1:1 (v:v) mixture of the
analyte solution and the matrix solution (1% or satu-
rated solution; acetonitrile-deionized water, 1:1) was
put on the MALDI sample plate with a 10-mL micropi-
pette (Eppendorf, Hamburg, Germany) equipped with
a 20-mL tip; 1.0 mL of the test solution was sampled with
the pipette, a drop was made on the top of the tip then
placed gently on the sample plate, and the plate was
allowed to stand to air dry prior to acquisition of the
MALDI-TOF mass spectra. Biocalc (Version 1.0, PerSep-
tive Biosystems) was used for all calculations of elemen-
tal composition and amino acid composition.
Angiotensins I and II, des-Arg(1)-bradykinin and
orcokinin were purchased from Sigma (St. Louis, MO).
a-Cyano-4-hydroxycinnamic acid (a-CHCA) was ob-
tained from Aldrich (Milwaukee, WI), and 4-hydroxy-
3-methoxycinnamic acid and trifluoroacetic acid (TFA)
were from Tokyo Kasei Kogyo (Tokyo, Japan). Solvents
were obtained from Wako Pure Chemical Industries
(Osaka, Japan) as HPLC grade materials. The matrixes
were recrystallized from methanol-deionized water,
and the other chemicals were used without further
purification. The analytes (Figure 1) and internal stan-
dards, Bu-2841-10, LI-F03, copiamycin, kuwanon H,
morusin and ikarisoside A, had been isolated in an
earlier study [5–9], and were stored in a freezer (at
230°C) until this experiment. These samples were dis-
solved in a 1:1 (v:v) mixture of acetonitrile:deionized
water to a stock solution and stored in the freezer. The
stock solution was diluted with a mixture of acetonitrile
and deionized water (1:1) before being deposited on the
plate. The a-CHCA solution was acidified with TFA
(final concentration is 0.1% TFA). Dowex 50W-X8 (50–
100 mesh) resin beads were purchased from Dow
Figure 1. Structures of analytes.
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Chemical (Midland, MI) and were used to desalt when
MNa1 and/or MK1 were observed in the MALDI-TOF
mass spectrum of the stock solutions except for ikariso-
side A. Approximately 80 mg of resin beads was added
to 0.5 mL of the stock solution. The amino acid and
NMR data used here were obtained in previous studies
in which 0.2 mg of sample was hydrolyzed for the
amino acid analysis and 5 mg peptide was used for
NMR measurements [5, 6].
Results and Discussion
As an example of the determination of molecular for-
mulas with MALDI-TOF MS, different types of com-
pounds, i.e., a linear peptide, two types of cyclic dep-
sipeptides, a polyhydroxy-macrocyclic lactone, and two
prenylated flavonoids, were analyzed by this method.
The protonated molecule of angiotensin II was mea-
sured by MALDI-TOF MS with delayed extraction in
reflector mode (25 pg of sample was deposited on the
MALDI plate) and was calibrated with internal stan-
dards, des-Arg(1)-bradykinin and angiotensin I. In pre-
liminary experiments, due to detector saturation, large
errors from the theoretical mass (more than 10 ppm)
were sometimes found in the spectra recorded with
high intensity peaks of the analyte and/or internal
standards. Errors were also recognized in noisy spectra
in which signal-to-noise ratio was less than 120. There-
fore, the data of these high intensity peaks and noisy
spectra were not used for the calculation shown in
Table 1. Increasing the amount of sample on the MALDI
plate (; 22 ng) did not adversely influence the mass
accuracy (absolute error) or precision (standard devia-
tion) as shown in Table 1. The number of possible
elemental compositions generated for the average mass
of protonated molecules (m/z 1046.5390) was 450 when
the following limits were applied: The composition
limits were C2–100, H3–100, N1–30, O2–30, and S0–10, and the
mass error limit was 66.6 mDa (62s; 95.5% confidence
level [10]). The calculation of possible amino acid com-
positions for the average mass with the same limits
gave 988 candidates.
Although a large list of possible elemental composi-
tions for MH1 of the natural compounds by the
MALDI-TOF MS measurement was generated as de-
scribed the above, the numbers of candidates could be
deduced from spectroscopic data and chemical infor-
mation. In the case of cyclic depsipeptides with aspar-
agine or glutamine residues, mass measurement of the
protonated molecules provided important information
for determination of the structure, because amino acid
analysis cannot detect the amino acids. The residues are
changed to aspartic acid and glutamic acid, respec-
tively, during hydrolysis process. Bu-2841-10 (1),
C68H100N16O21 (Mw 1476), is a mixture of four cyclic-
depsipeptide antibiotics with the same molecular for-
mula. The peptides consist of 12 amino acid residues
including a d-asparagine, d- and l-aspartic acids, and
two unusual amino acids (d- and l-2,4-diaminobutyric
acid). Furthermore, the antibiotics have a long side
chain consisting of d-serine and b-hydroxy carboxylic
acid [5]. High-resolution FAB-MS was incapable of
determination of the formula because of the limited
quantity of available sample. Thus, the formula was
determined with low resolution FAB-MS and NMR
data along with amino acid analysis.
Table 1. Experimental masses successfully determined by MALDI-TOF mass spectrometry
Trivial name
Means (Da)
(number of spectra)
Mass error
in ppm
(in mDa)
Amounts of
sample
(per spot) sa (mDa)
Resolution
(FWHM) Isb
Angiotensin II 1046.540 (10) 22 (22) 25 pg 2 9200–10 000 A, B
1046.540 (9) 23 (23) 220 pg 2 9000–11 900 A, B
1046.539 (9) 23 (23) 2 ng 3 10 900–13 000 A, B
1046.541 (9) 21 (21) 22 ng 3 7900–11 500 A, B
Bu-2841-10 (1) 1477.733 (10) 60 (60) 7 ng 3 10 200–14 200 A, C
LI-F03a (2) 947.556 (12) 21 (21) 2 ng 2 11 900–12 800 B, D
947.558 (11) 11 (11) 2 ng 2 11 900–12 800 B, E
LI-F03b (3) 961.571 (10) 22 (22) 0.6 ng 3 10 000–12 100 B, D
Copiamycin (4) 1058.671 (11) 23 (23) 2 ng 2 9500–11 700 A, D
Kuwanon H (5)c 761.297 (7) 60 (60) 40 ng 2 7600–8700 B, F
Morusin (6)d [M 1 H]1 421.166 (11) 11 (11) 27 ng 3 4100–6300 G, H
[M 1 OH]1 437.161 (12) 12 (11) 27 ng 2 G, H
[M 1 OOH]1 453.156 (11) 12 (11) 27 ng 5 G, H
aSigma is the standard deviation in the mean obtained from the individual differences between the repeated experiments and the overall mean [10].
bThe amounts of the internal standards were almost the same as the analyte in molar ratio except in the case of E. Internal standards; A: angiotensin
I (MH, 1296.6853 Da), B: desArg(1)-bradykinin (MH, 904.4681), C: orcokinin (MH, 1517.6661), D: angiotensin II (MH, 1046.5423), E: LI-F03b (MH,
961.5723), F: 4-hydroxy-3-methoxycinnamic acid (3M 1 Na, 605.1639), G: a-CHCA (2M 1 H, 379.3500), H: ikarisoside A (8-prenylkaempferol-3-O-a-
rhamnopyranoside, M 1 Na, 523.1580).
cTwo formulas, C45H44O11 and C23H28N28O4, were postulated when the IHD number 24 was applied. Spectroscopic and chemical data indicated that
the compound consisted of two cyclic moieties, four aromatic rings, four double bonds, and two carbonyl, five methyl, three methylene, and three
methine groups.
dThe candidates of the formula for the protonated molecule with the calculation using the limits of the composition (C1–30, H3–60, N0–20, and O3–20), 6
2s, and nitrogen rule were C5H21N14O9 (IHD number, 3), C6H17N18O5 (8), C9H25N8O11 (2), C10H21N12O7 (7), C11H17N16O3 (12), C13H29N2O13 (1),
C14H25N6O9 (6), C15H21N10O5 (11), C18H29O11 (5), C20H25N2O8 (10), C21H21N6O4 (15), and C25H25O6 (14).
460 FUKAI ET AL. J Am Soc Mass Spectrom 2000, 11, 458–463
The average mass of MH1 of the compound (1)
determined by MALDI-TOF MS was 1477.7326 Da
(Table 1). One-handled 22 possible elemental composi-
tions were calculated for the average mass with elemen-
tal limits of C2–105, H3–210, N1–30, and O2–30 and 6 2s
confidence level (66.8 mDa). 59 compositions with odd
numbers of nitrogen atoms were deleted from the list
by the nitrogen rule. Amino acid analysis indicated that
the composition of the peptide moiety was
C57H78N15O20 (including Asp 3 3), C57H79N16O19
(Asp 3 2, Asn 3 1), C57H80N17O18 (Asp 3 1, Asn 3 2),
or C57H81N18O17 (Asn 3 3) in view of the possibility of
the cyclic structure and the change of asparagines to
aspartic acids during hydrolysis. When the data were
used as the lower limit compositions (C57, H78, N15, and
O17) for the calculation of possible formulas, the 63
candidates were decreased to 9 compositions. The index
of hydrogen deficiency (IHD, unsaturation number) of
the possible elemental compositions of the peptide
structures described above was 26. The cyclic structure
of the compounds was shown by FAB MS of 1 in which
no fragment ions were observed except those originat-
ing from decomposition of the side chain. The structure
was also confirmed by hydrolysis of 1 to linear peptides
under basic condition. Therefore, the IHD of the pep-
tide structures in the antibiotics was 26. In the last list,
five formulas (not protonated molecules) had IHD
numbers lower than 25; i.e., C61H105N16O26 (IHD, 18),
C57H101N22O24 (19), C63H101N18O23 (23), C58H97N26O20
(24), and C59H97N24O21 (24). On the other hand, four
candidates, C68H101N16O21 (IHD of formula, 27),
C64H97N22O19 (28), C60H93N28O17 (29), and
C69H97N20O17 (32), had IHD numbers higher than that
of the peptide moiety (26). The formula of the com-
pound can be easily deduced among the remaining
candidates by NMR data as follows. The IHD number
of the remaining group (fatty acid moiety) can be
confirmed from the coupling patterns and chemical
shifts of protons and carbons (i.e., methyl, methylene,
olefin, methine with oxygen or nitrogen functional
groups, carbonyl groups, etc.). The NMR data of the
peptides indicated that the fatty acid moieties consisted
of methyl, methylene, and methine groups, a hydroxyl,
and a carbonyl group (IHD, 1). Thus, the formula of the
protonated molecule was deduced as C68H101N16O21.
Recently, the antifungal peptide LI-F03 was identi-
fied as a 3:2 mixture of cyclic hexapeptides with an alkyl
side chain with a terminal guanidino group [6]. The
antibiotics, LI-F03a (2) and LI-F03b (3), may be identi-
fied as fusaricidins C and D [11], respectively. These
peptides have a d-asparagine or d-glutamine residue.
With a combination of amino acid analysis and NMR
spectroscopy, MALDI-TOF MS of the peptides was also
able to determine the molecular formulas as shown in
Table 2. Huang et al. reported that when analytes are
calibrated with standards of the same class of material,
correct exact mass measurements with MALDI-TOF MS
were achieved (,10 ppm), but when analytes were
calibrated with standards originating from a different
class of material, unacceptable mass accuracies were
often observed (. 10 ppm) [12]. The accuracy and
precision of protonated molecule of LI-F03a (2) cali-
brated with linear peptides were almost the same to
those indicated with calibration using of a linear pep-
tide and cyclic depsipeptide (3) as shown in Table 1.
A model of distributions of monoisotopic masses for
all possible peptides for a given integer (nominal) mass
was reported by Zubarev et al. [13]. They reported that
the number of unique elemental compositions for a
peptide with a molecular mass of 1000 Da is ;2.3
compositions per mDa and the mass accuracy of 0.4
mDa should be sufficient to unequivocally determine
the peptide composition. For the mass accuracy of
about 61 ppm currently achieved for peptides with
mass spectrometry (FAB), the limit to determine the
unique elemental composition of a peptide is 700–800
Da. The mass accuracy and precision of MALDI-TOF
MS are less than those of FAB, electrospray ionization
(ESI) [1], and Fourier-transfer ion cyclotron resonance
(FT-ICR) [14] mass spectrometry. Nevertheless, when
combined with amino acid analysis and 1H NMR data,
the MALDI-TOF method can determine the formulas of
unknown peptides as described above.
The antifungal agent copiamycin (4), C54H95N3O17
(Mw 1057), is a 32-membered polyhydroxy-macrocyclic
lactone with a guanidino alkenyl side chain [15]. The
average mass of protonated molecule (m/z 1058.6714) gave
46 elemental compositions with the elemental limits C1–75,
H3–150, N0–30, and O0–30 and mass error limit (62s 5 63.5
mDa). 24 formulas remained when the nitrogen rule was
Table 2. Candidates of protonated molecules of 2 and 3 with some parameters
Application 2 Candidates 3 Candidates
Average mass (Da) 947.5555 961.5708
2s (mDa) 4.5 54 5.2 60
N-rule 28 30
Lower limita C29H41N6O10 9 C30H43N6O10 9
IHD of peptideb 12 2 12 2
IHD of side chainc 2 1 2 1
Molecular formula C45H74N10O12 C46H76N10O12
aLower limit composition from amino acid analysis.
bIndex of hydrogen deficiency of the peptide moiety in the antibiotic from amino acid analysis.
cIndex of hydrogen deficiency of the fatty acid moiety from 1H and 13C NMR data.
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applied. 13C NMR spectrum of the antibiotics (in CD3OD)
indicated the IHD number of the compound to be 9 [three
double bonds (IHD, 3), bicyclic structure (2), three car-
bonyl groups (3), and guanidino (1) groups]. Of the
candidates, only one formula (C54H96N3O17) had the IHD
number (9). Thus, the formula of copiamycin (4) was
concluded to be C54H95N3O17.
Kuwanon H (5), C45H44O11 (Mw 760), was isolated as
a hypotensive agent from a traditional Chinese medi-
cine [7]. The compound is a Diels–Alder type adduct
with prenylated chalcone and flavone. The average
mass of protonated 5 determined by MALDI-TOF MS
was 761.2965 Da (2s 5 4 mDa). 50 candidates were found
for the protonated molecule with the error limit (6 2s)
and the elemental limits of C1–55, H3–110, N0–30, and O2–30.
When the nitrogen rule was applied to the list (nitrogen
numbers were zero or even numbers), 27 formulas re-
mained. The 1H and 13C NMR spectra and chemical
information of 5 indicated the presence of 45 carbons in
the molecule. Among the candidates, only one formula
(C45H45O11) had 45 carbons. Thus, the molecular formula
of kuwanon H (5) was deduced to be C45H44O11.
Morusin (6), C25H24O6 (Mw 420), is a flavone with a
3-prenyl group [8]. In combination with NMR spectros-
copy, MALDI-TOF MS of 6 was also able to determine
the formula of the protonated molecule. Recently, we
reported that the laser desorption/ionization time-of-
flight mass (LDI-TOF MS, without matrix) and MALDI-
TOF MS of an amorphous solid of the compound gave
oxide ions [M 1 OH]1 and [M 1 OOH]1. These ad-
duct ions were not observed with LDI-TOF MS of a
single crystal of the compound [16]. We speculated that
the observation of oxide ions admitted the presence of
an oxygen pocket on the molecule in the amorphous
solid state and the pocket held an oxygen molecule. The
composite may correspond to a contact-charge-transfer
complex [morusin . . . O2] in the ground state of
morusin in solution that was postulated earlier in the
photocyclization mechanism of the flavone (Scheme 1)
[16, 17]. Previously [16], we reported briefly that the
formulas of these adduct ions could be determined with
MALDI-TOF MS, and the elemental compositions of the
ions corresponded to those of the reaction products (7
and 8) with the photocyclization of morusin [17], re-
spectively. The more detailed measurements here indi-
cated that the average mass of the oxide ion [M 1 OH]1
was 437.1607 Da and that of [M 1 OOH]1 was 453.1558
Da. The candidate formulas of the former ion were
C25H25O7 and C13H29N2O14, and those of the latter were
C25H25O8, C18H29O13, C20H25N2O10 and C13H29N2O15
when the mass error limit (6 2s), allowed atoms (C1–30,
H3–60, N0–2, and O3–20), and the nitrogen rule were used
for the calculation. The first formulas for each of the
candidates corresponded to the photoreaction products
8 (C25H24O7) and 7 (C25H24O8) of morusin in solution.
The other formulas were neglected for the following
reasons: (1) the formation of the other candidate formu-
las required many consequent reactions in the LDI and
MALDI conditions; (2) the oxide ions were observed by
laser at threshold fluence for the compound in which no
fragment ions appeared; (3) the adduct ions were also
observed under nitrogen-free conditions (a single crys-
tal of morusin was dissolved in methanol); and (4)
oxide ions were not observed on LDI-TOF MS of a
single crystal of morusin. Thus, photo-oxidation of
morusin probably occurred under these LDI and
MALDI conditions. Accurate mass measurement with
LDI-TOF or MALDI-TOF MS will be powerful tools for
photochemistry when the reaction products or interme-
diates are too unstable to isolate.
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